Mounjaro vs Rybelsus: Full Comparison (2026)
How does Mounjaro (Tirzepatide) compare to Rybelsus (Semaglutide (oral))? We break down the weight loss data, pricing, side effects, and who each medication is best suited for.
Mounjaro (Tirzepatide, Dual GLP-1/GIP receptor agonist) and Rybelsus (Semaglutide (oral), GLP-1 receptor agonist) work through different mechanisms. Mounjaro is FDA-approved for type 2 diabetes with 15-22% of body weight average weight loss at $1,023/mo. Rybelsus is approved for type 2 diabetes with 5-10% of body weight average weight loss at $936/mo.
Side-by-Side Comparison
| Feature | Mounjaro | Rybelsus |
|---|---|---|
| Active Ingredient | Tirzepatide | Semaglutide (oral) |
| Mechanism | Dual GLP-1/GIP receptor agonist | GLP-1 receptor agonist |
| FDA Approved For | Type 2 diabetes | Type 2 diabetes |
| Doses | 2.5mg to 15mg (weekly injection) | 3mg, 7mg, 14mg (daily oral tablet) |
| Administration | Weekly subcutaneous injection | Daily oral tablet on empty stomach |
| Avg. Weight Loss | 15-22% of body weight | 5-10% of body weight |
| Monthly Price | $1,023 | $936 |
| Oral Available | No | Yes |
| Year Approved | 2022 | 2019 |
Prices reflect typical self-pay costs without insurance. Actual costs vary by pharmacy, location, and insurance plan. Last updated March 2026.
Which Produces More Weight Loss?
Based on clinical data, Mounjaro produces more weight loss on average (15-22% of body weight) compared to Rybelsus (5-10% of body weight). Mounjaro uses Tirzepatide (Dual GLP-1/GIP receptor agonist), while Rybelsus uses Semaglutide (oral) (GLP-1 receptor agonist), which may account for the difference.
First dual GLP-1/GIP receptor agonist. Approved for type 2 diabetes, used off-label for weight loss. Generally shows greater weight loss than semaglutide alone.
First oral GLP-1 medication. Lower doses than injectable semaglutide, resulting in less weight loss. Convenient for patients who prefer pills over injections.
Which Costs Less?
At list price, Rybelsus is the more affordable option at $936/month compared to $1,023/month for Mounjaro. However, actual out-of-pocket costs depend heavily on your insurance plan. Mounjaro with insurance: $25-$200/month with Lilly savings card. Rybelsus with insurance: $10-$150/month typical copay.
Eli Lilly savings card for eligible patients
Manufacturer savings programs available
Side Effects Comparison
Both Mounjaro (Dual GLP-1/GIP receptor agonist) and Rybelsus (GLP-1 receptor agonist) share similar gastrointestinal side effects, which are the most commonly reported:
- Nausea (most common for both medications)
- Diarrhea and vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Headache, fatigue, dizziness (less common)
Serious but rare side effects for both include pancreatitis, gallbladder problems, and kidney issues. Both carry warnings about medullary thyroid carcinoma risk based on animal studies. Always discuss your full medical history with your doctor before starting either medication.
Which Should You Choose?
The best choice depends on your diagnosis, insurance coverage, weight loss goals, and personal preferences. Here is our general guidance:
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -Cost is a concern ($1,023/month at list price)
- -You want the dual GLP-1/GIP mechanism for potentially greater efficacy
- -You prefer the convenience of once-weekly dosing
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -You prefer an oral option over injections
- -Cost is a concern ($936/month at list price)
- -You prefer a daily dosing routine
Find the Best GLP-1 Provider for You
Compare verified telehealth programs that prescribe Mounjaro, Rybelsus, and other FDA-approved GLP-1 medications.
Frequently Asked Questions
Can I switch from Mounjaro to Rybelsus?
Switching between Mounjaro and Rybelsus is possible but requires medical supervision since they contain different active ingredients (Tirzepatide vs Semaglutide (oral)). Your doctor will determine the appropriate starting dose and titration schedule for the new medication.
Which is better for weight loss: Mounjaro or Rybelsus?
Clinical data suggests Mounjaro produces more weight loss on average (15-22% of body weight) compared to Rybelsus (5-10% of body weight). However, individual results vary significantly based on dosing, diet, exercise, and metabolic factors.
Is Mounjaro cheaper than Rybelsus?
At list price, Rybelsus ($936/month) is less expensive than Mounjaro ($1,023/month). With insurance, costs vary significantly. Mounjaro: $25-$200/month with Lilly savings card. Rybelsus: $10-$150/month typical copay.
Do Mounjaro and Rybelsus have the same side effects?
Both medications share similar gastrointestinal side effects (nausea, diarrhea, vomiting, constipation) as these are common to GLP-1 receptor agonists. However, since they contain different active ingredients, there may be differences in frequency and severity. Discuss your medical history with your doctor to determine which has a better safety profile for you.
Does insurance cover Mounjaro and Rybelsus?
Coverage varies by plan. Mounjaro is FDA-approved for type 2 diabetes — insurance coverage is typically better for on-label use. Rybelsus is FDA-approved for type 2 diabetes. Check with your specific insurance plan and ask your doctor about prior authorization requirements.